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This letter is based on my experience of technical meet-
ings aimed at preparing documents on vaccination pro-
grammes for the Conferenza Stato Regioni.
The message I would like to convey is that these tech-
nical committees are often made up not of healthcare 
personnel, but of administrative staff members who are 
not experts and who consider only political/administra-
tive aspects.
In Italy, the National Health Service has been decentral-
ized since 2001. This means that all 21 Italian Regions, 
with the strategic support of the Ministry of Health, are 
responsible for organizing and delivering all health serv-
ices, and for allocating the necessary budgets. 
With regard to vaccinations, a National Vaccination 
Committee has been established. This Committee is com-
posed of representatives of the Regional Health Authori-
ties, Ministry of Health, National Institute of Health and 
scientific societies and has the task of drawing up the Na-
tional Immunization Plan. Each Region appoints repre-
sentatives, who participate in technical board meetings. 
However, these representatives do not always possess the 
expertise required for the important decisions that they 
are called upon to take.
I have taken part in many meetings of technical boards 
dealing with the phases of introduction into vaccination 
calendars of various vaccines, such as anti-pneumococcal 
conjugate vaccine (PCV) and anti-meningococcal C con-
jugate vaccine (Men C). The debate preceding the final 
approval of the introduction of these vaccines into the Ital-
ian immunization schedule was laborious and excessively 
long. Some Regions, which apply the opinions of experts, 
had introduced the meningococcal C and pneumococcal 
vaccinations before their approval at the national level. 
Differences in target groups and types of offer can still be 
observed. This condition gave rise to a “patchwork” and 
consequently the vaccination coverage rates were very 
different from Region to Region. 
In 2006, PVC and Men C vaccinations were introduced in 
my Region, Valle d’Aosta, where few cases of meningitis 
disease were registered annually. However, a laboratory 
that uses PCR methods to detect the microorganisms in-
volved is not available. The vaccination coverage rate for 
Men C was 84.3% in 2009 and 86.0% in 2010. The PVC 
vaccination coverage rate was 85.0% in 2009 and 89.7% 
in 2010. No cases of meningitis disease have been report-
ed in the last few years and paediatricians have observed 
a decrease in otitis of about 60%. This approximate evalu-
ation indicates the considerable advantages conferred by 
vaccinations.
It is important to raise public awareness of the benefits of 
immunization programmes. Moreover, the culture of im-
munization programmes needs to be spread to decision-
makers, who play a key role in the choice of health strate-
gies. In addition, university research should increasingly 
promote the prevention of infectious diseases through 
vaccination. 
Finally, I hope that the technical working groups are com-
posed of highly qualified medical personnel.
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